On May 22, 2024, Strides Pharma Science Limited (Strides) informed in an exchange filing that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has got a nod from the United States Food & Drug Administration (US FDA) for the generic version of Sucralfate Oral Suspension, 1gm/10 mL. Sucralfate Oral Suspension is bioequivalent …